I Negishi
Overview
Explore the profile of I Negishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
1064
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shibusawa Y, Negishi I, Tabata Y, Ishikawa O
Rheumatology (Oxford)
. 2008 Mar;
47(4):454-7.
PMID: 18316335
Objective: Animal models are useful tools to study various aspects of human diseases. Bleomycin (BLM)-induced scleroderma mouse has been widely investigated as an animal model of scleroderma. Repeated injections of...
2.
Shibusawa Y, Negishi I, Ishikawa O
Int J Dermatol
. 2006 Mar;
45(3):302-5.
PMID: 16533235
We describe two cases of a 3-year-old Japanese boy and his 1-year-old sister presenting recessive dystrophic epidermolysis bullosa; a relatively mild phenotype. Blistering and scarring were limited to the acral...
3.
Shimizu A, Takahashi A, Negishi I, Tamura A, Ishikawa O
Dermatology
. 2003 Dec;
207(4):426-7.
PMID: 14657647
No abstract available.
4.
Motegi S, Tamura A, Endo Y, Kato G, Takahashi A, Negishi I, et al.
Br J Dermatol
. 2003 Jan;
148(1):180-2.
PMID: 12534626
No abstract available.
5.
Endo Y, Negishi I, Ishikawa O
Rheumatology (Oxford)
. 2002 May;
41(5):490-5.
PMID: 12011370
Objectives: Microchimerism of foetal cells occurs during most pregnancies. Two autoimmune diseases, systemic sclerosis (SSc) and Sjögren's syndrome (SS), have many clinical and pathological similarities to chronic graft-vs-host disease (GVHD)....
6.
Shirane M, Sawa H, Kobayashi Y, Nakano T, Kitajima K, Shinkai Y, et al.
Development
. 2001 Dec;
128(24):5173-80.
PMID: 11748152
Phospholipase C-gamma1 (PLC-gamma1) is involved in a variety of intracellular signaling via many growth factor receptors and T-cell receptor. To explore the role of PLC-gamma1 in vivo, we generated the...
7.
Iwabuchi K, Iwabuchi C, Tone S, Itoh D, Tosa N, Negishi I, et al.
Blood
. 2001 Mar;
97(6):1765-75.
PMID: 11238119
Development of natural killer 1.1+ (NK1.1+) CD3+ (NK1.1+ T) cells was analyzed in zeta-associated protein 70 (ZAP-70) null ((-/-)) mice. Both NK1.1+ TCRalphabeta+ and NK1.1+ TCRgammadelta+ cell populations were absent...
8.
Tone S, Iwabuchi K, Iwabuchi C, Negishi I, Onoe K
Immunol Lett
. 2000 Aug;
73(1):65-9.
PMID: 10963813
The mechanism of development of a unique subset of T cells, thymic NK1.1(+) alpha beta T cells, has been poorly understood. We found that the development of thymic NK1.1(+) alpha...
9.
Ato M, Iwabuchi K, Matsuki N, Mukaida N, Iwabuchi C, Takahashi A, et al.
Immunobiology
. 2000 Apr;
201(3-4):432-49.
PMID: 10776798
A human monocyte chemoattractant protein-1 (hMCP-1) transgenic mouse (Tgm) line which constitutively produces a large amount of hMCP-1 (7-13 ng/ml in the serum) was established. Although expression of the transgene...
10.
Hamasaki A, Sendo F, Ishida N, Negishi I, Nakayama K, Hatakeyama S
J Exp Med
. 1998 Dec;
188(11):1985-92.
PMID: 9841913
To elucidate the role of A1, a new member of the Bcl-2 family of apoptosis regulators active in hematopoietic cell apoptosis, we established mice lacking A1-a, a subtype of the...